Expertise in
14
conditions

Dr. Amir Azadi

Oncology | Neurology
2222 E Highland Ave, Suite 400, 
Phoenix, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
14
conditions
2222 E Highland Ave, Suite 400, 
Phoenix, AZ 

Overview

Amir Azadi is an Oncologist and a Neurologist practicing medicine in Phoenix, Arizona.

Dr. Azadi is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Gliosarcoma, Glioblastoma, Astrocytoma, and Embryonal Tumor with Multilayered Rosettes.

Dr. Azadi is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 3 clinical trials. Dr. Azadi is currently accepting new patients.

Specialties

Oncology
Neurology

Licenses

Internal Medicine in AZ

Board Certifications

Internal Medicine (Sub: Medical Oncology)
Internal Medicine

Fellowships

Barrow Neurological Institute
James Graham Brown Medical Center

Hospital Affiliations

St Josephs Hospital And Medical Center
Honorhealth Scottsdale Shea Medical Center
Honorhealth Scottsdale Thompson Peak Med Ctr
Honorhealth Scottsdale Osborn Medical Center
Honor Health John C. Lincoln Medical Center

Languages Spoken

English
Farsi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Arizona Oncology Associates, PC
2222 E Highland Ave, Suite 400, Phoenix, AZ 85016

Additional Areas of Focus

Dr. Azadi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
View 2 Less Clinical Trial

10 Total Publications

Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox.
Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox.
Journal: Neuro-oncology practice
Published: March 27, 2023
Similar Doctors
Expertise in
18
conditions
Dr. Yoshie Umemura
Oncology | Neurology
Expertise in
18
conditions
Dr. Yoshie Umemura
Oncology | Neurology
Referral may be required
Before you request

Barrow Neuro-Oncology

2910 N 3rd Ave, Suite 470, 
Phoenix, AZ 
 (3.1 miles away)
602-406-6387
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Yoshie Umemura is an Oncologist and a Neurologist practicing medicine in Phoenix, Arizona. Dr. Umemura is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Astrocytoma, and Glioblastoma. Dr. Umemura is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral required
Before you request

Barrow MAMDC And Barrow Cognitive

240 W Thomas Rd, Ste 301, 
Phoenix, AZ 
 (3.1 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marwan Sabbagh is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Sabbagh is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Lewy Body Dementia (LBD), Movement Disorders, and Deep Brain Stimulation. Dr. Sabbagh is board certified in Psychiatry & Neurology (Neurology). Dr. Sabbagh is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Neurosurgical Associates LTD.

2910 N 3rd Ave, 
Phoenix, AZ 
 (3.1 miles away)
602-406-3181
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Jadhav is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Jadhav is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Stroke, Subarachnoid Hemorrhage, Brain Aneurysm, Thrombectomy, and Stent Placement.

Frequently Asked Questions about Dr. Amir Azadi

How do I make an appointment with Dr. Amir Azadi?

You can book an appointment with Dr. Amir Azadi by calling their office at 602-277-4868. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amir Azadi a top-rated expert for Gliosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amir Azadi is classified as an Distinguished expert for Gliosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amir Azadi specialize in?

While Dr. Amir Azadi is a Oncology, they have specific expertise in Gliosarcoma, Glioblastoma, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Amir Azadi participate in research or clinical trials?

Yes. Dr. Amir Azadi has published 10 articles and abstracts on conditions like Gliosarcoma. You can view a list of Dr. Amir Azadi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amir Azadi accept my insurance?

Dr. Amir Azadi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 602-277-4868 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Azadi's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
      View All 32 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile